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Abstract.  Signal recognition particle (SRP) plays the 
key role in targeting  secretory proteins to the mem- 
brane of the endoplasmic reticulum (Walter,  P., and 
V. R.  Lingappa.  1986.  Annu.  Rev.  CeliBiol. 
2:499-516).  It consists of SRP7S RNA and six pro- 
teins.  The 54-kD protein of SRP (SRP54) recognizes 
the signal sequence of nascent polypeptides. The  19- 
kD protein of SRP (SRP19) binds to SRP7S RNA 
directly and is required for the binding of SRP54 to 
the particle.  We used deletion mutants of SRP19 and 
SRP54 and an in vitro assembly assay in the presence 
of SRP7S RNA to define the regions in both proteins 
which are required to form a ribonucleoprotein parti- 
cle.  Deletion of the 21  COOH-terminal amino acids of 
SRP19 does not interfere with its binding to SRP7S 
RNA.  Further deletions abolish SRP19 binding to 
SRP7S RNA.  The COOH-terminal 207 amino acids of 
SRP54 (M domain) were found to be necessary and 
sufficient for binding to the SRP19/7S RNA complex 
in vitro.  Limited protease digestion of purified SRP 
confirmed our results for SRP54 from the in vitro 
binding assay.  The SRP54M domain could also bind 
to Escherichia  coli 4.5S RNA that is homologous to 
part of SRP7S RNA.  We suggest that the methionine- 
rich COOH terminus of SRP54 is a RNA binding do- 
main and that SRP19 serves to establish a binding site 
for SRP54 on the SRP7S RNA. 
S 
ECRETORY and membrane proteins contain signal  se- 
quences required for their targeting  to the ER (Walter 
and Lingappa,  1986). Signal recognition particle (SRP) l 
recognizes the signal sequence of nascent polypeptide chains, 
binds to them and retards elongation  (Walter and Lingappa, 
1986; Wolin and Walter, 1989). Upon interaction with dock- 
ing protein (DP), the SRP receptor in the ER membrane, 
elongation  resumes and the nascent chain  is translocated 
(Gilmore et al.,  1982; Meyer et al.,  1982). 
SRP consists  of SRP7S RNA (Walter and Blobel,  1982) 
and six different protein subunits of 9, 14, 19, 54, 68 and 72 
kD molecular mass (Siegel and Walter,  1988c).  7S RNAs 
and smaller RNAs that are similar  to parts of SRP7S RNA 
have been found in a wide range  of organisms  (Brennwald 
et al.,  1988; Gundelfinger  et al.,  1984; Ribes et al.,  1988; 
Haas et al., 1988; Struck et al., 1988). Whereas the primary 
sequence may vary considerably the secondary structure of 
these molecules is highly conserved (Poritz et al., 1988). We 
have recently shown that secretion of/~-lactamase  in Esche- 
richia coli involves a ribonucleoprotein complex composed 
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1. Abbreviations used in this paper: DP, docking protein; SRP, signal recog- 
nition  particle;  SRP54M,  methionine-rich  COOH  terminus  of SRP54 
(amino acids 297-504); SRP54N+G domains, amino acids 1-295 of SRP54, 
containing  a putative GTP-binding site. 
of 4.5S RNA that is homologous to stem-loop 2 of SRPTS 
RNA (Poritz et al., 1988) and a 48-kD protein (fib) homolo- 
gous to SRP54 (Bystr6m et al., 1983; R6misch et al., 1989; 
Bernstein  et al.,  1989; Ribes et al.,  1990). 
Of the protein components SRP9 and SRP14 bind to the 
SRP7S RNA as heterodimer and are required for elongation 
retardation  (Siegel and Walter, 1988b,c). SRP68 and SRF72 
also form a heterodimer and are essential for interaction with 
DP in the ER membrane (Siegel and Walter, 1988b,c). SRP19 
binds to SRP7S RNA alone (Siegel and Walter, 1988b; Lin- 
gelbach et al., 1988). Footprinting  experiments indicate that 
SRP19 contacts the two stem-loops of SRP7S RNA (Siegel 
and Walter, 1988a). The binding of SRP54 to the particle re- 
quires the presence of SRP19  (Siegel  and  Walter, 1988b; 
R6misch et al.,  1989). We have shown recently that SRP54 
alone binds to E.  coli 4.5S RNA (Ribes et al., manuscript 
submitted for publication) and suggested therefore that SRP19 
binding to SRFTS RNA exposes a binding site for SRP54 on 
the RNA. SRP54 has also been shown to bind to the signal 
sequence of nascent polypeptide chains by cross-linking  ex- 
periments (Krieg et al.,  1986; Wiedmarm et al.,  1987). 
SRP54 has been found to be similar to three other proteins 
(R6misch et al., 1989; Bernstein et al., 1989): DP, which is 
the receptor for SRP at the ER membrane (Lauffer et al., 
1985; Hortsch et al., 1988); FTS Y, which is an E. coli pro- 
tein of unknown  function  (Gill et al.,  1986) and an E.  coli 
48-kD protein (Bystr6m et al., 1983). The COOH-terminal 
300-amino acid residues of DP and FTS Y are similar to the 
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protein can be aligned with SRP54  over its entire length 
(Rfmisch et al.,  1989;  Bernstein et al.,  1989).  The align- 
ments of both DP and FTS Y with SRP54 end at almost ex- 
actly the same position within SRP54, namely at amino acid 
297 and 299, respectively. We assume that this indicates the 
end of a functional domain that SRP54 has in common with 
the other proteins and possibly also the end of a structural 
domain. 
The protein components of SRP can be released from the 
RNA under non-denaturing conditions (Siegel  arid Walter, 
1988b; Scoulica et al., 1987) and reassembly of a complete 
SRP (Siegel and Walter,  1988b) or a subparticle (Siegel and 
Walter,  1988b;  Lingelbach et al.,  1988;  R6misch et al., 
1989) is possible in vitro. We used this approach to locate 
the regions in SRP19 and SRP54 which are required for as- 
sembly into a SRP subparticle. Proteolytic cleavage of SRP 
purified from dog pancreas and subsequent analysis of the 
resulting SRP54 fragments support our in vitro data. 
Materials and Methods 
Constructs 
SRPI9 and Derivatives.  Plasmid pSRP19 has been described previously 
(Lingelbach et al.,  1988).  Truncated SRPI9 polypeptides were created by 
three methods: (a)  linearization of pSRP19 within the coding region by 
Xba I causes synthesis of only the N2-terminal 68 amino acids of SRP19 
in the subsequent in vitro transcription and translation. (b) The other car- 
boxy-terminal truncations were generated by adding synthetic oligonucleo- 
tides complementary to part of the coding region to the in vitro translation 
reaction (Haeuptle et al.,  1986).  The wheat germ endogenous RNase H 
cleaves the message at the hybridization site and the truncated mRNA gives 
rise to a shortened SRP19.  The oligonucleotides used are SRP19/3  (com- 
plementary to coding bases 460-476),  SRP19/8 (404-420)  and SRP19/7 
(344-360).  (c) Plasmid pSRP19X/H was constructed as follows: pSRP19 
was digested with Xba I and the vector pDS12/RBSII (Bujard et al., 1987) 
with Sal I. Both linearized DNAs were made blunt end with Klenow (Mani- 
atis et al.,  1982)  and then digested with Hind III.  The  resulting Hind 
m/blunt  fragment  from  pSRP19  containing  the  coding  region  for  the 
COOH-terminal 75 amino acids was ligated to the pDS12/RBSII vector. 
SRP54 and Derivatives. pSRP54TEx and pSRP54-1 were described pre- 
viously (R6misch et al.,  1989).  In vitro transcription and translation of 
pSRP54-1  gives rise to the full length 54-kD protein, pSRP54TEx contains 
the coding region for only the COOH-terminal 35-kD segment of SRP54 
(SRP54Ex).  COOH-terminal  deletion mutants  were  created  by  cutting 
pSRP54-1  within the coding region with Bgl II, Barn HI, Eco RI, Hind III, 
or Sph I before transcription. 
pSRP54B* was generated as follows: the nucleotides around the starting 
methionine of SRP54 were changed to a Nco I site by site-directed mutagen- 
esis in M13. The Nco I/Barn HI* fragment was cut out and introduced into 
pDS56/RBSII-6xHis  (Hochuli et al.,  1988).  This construct contains the 
coding region for the first 466 amino acids of SRP54 plus an additional 6 
histidine residues at the COOH-terminus, which can be used for affinity 
purification on a metal chelating column (Hochuli et al.,  1988). 
The  Nco I/Barn  HI  fragment encoding the  first  166  amino acids of 
SRP54 and the Barn HI/Barn  HI* fragment encoding amino acids  167- 
466  of SRP54 were introduced into pDS56/RBSII-6xHis  (pSRP54 t-166, 
pSRP54t67-466),  These plasmids were used for overproduction of the en- 
coded SRP54-derived peptides. 
The SRP54N +G polypeptide was generated by translation of the SRP54 
mRNA in presence of an oligonucleotide complementary to coding bases 
886-897.  pSRP54M,  site-directed mutagenesis in M13  was to  create a 
Nco I site around the methionine at position 297 of SRP54. The mutated 
fragment was cut out with Nco I/Pst I, made blunt end, and cloned into the 
Sma I site of pGEM2 (Promega Biotec, Madison, WI). 
General  molecular biology techniques were performed according to 
Maniatis et al.  (1982). 
Binding Experiments 
Formation  of  a  RNP  was  tested  essentially  as  described  previously 
(R6misch et al., 1989). Linearized DNA was transcribed in vitro and trans- 
lated in the wheat germ cell-free system in the presence or absence of trun- 
caring oligonucleotides for 30 min at 25°C. EDTA was added to 5 mM final 
concentration to release nascent chains from ribosomes and incubation was 
continued for 15 min. Then the translation reactions were adjusted to 5 mM 
magnesium acetate and 500 mM potassium acetate.  10 ~1 translation of 
SRP54, SRP19, or truncation thereof were mixed with 1 t~g SRP'/S RNA 
or tRNA and incubated at 25°C for 30 min. The volume was adjusted to 
200/~1 with 500 mM potassium acetate, 5 raM magnesium acetate, 50 mM 
Tris-acetate, pH 7.5 (wash buffer). 40 #1 were removed and TCA precipi- 
tated to monitor for total protein synthesis (T). 30 ~1 DEAE-Sepharose CL- 
6B (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated in wash buffer 
was added to the remainder and incubated at 4°C for 15 min. After centrifu- 
gation the unbound supernatant fraction (U) was TCA precipitated. The 
DEAE-Sepharose was  washed three times with  1  mi  wash buffer and 
DEAE-bound material was released by a 15 rain incubation at 4°C with 200 
#1 of the same buffer adjusted to 2 M potassium chloride. Eluted protein 
was TCA precipitated and all samples were analyzed on 10-15% Laemmli- 
type SDS polyacrylamide gels (Laemmli,  1970) and subjected to fluorog- 
raphy. 
Antibodies 
Rabbit antisera 908 and 907 were raised against SRP54 derived peptides 
overexpressed in E.  coli from pSRP54 t-166 and pSRP54167-466, respec- 
tively,  and purified on a nickel chelating column as described (Hochuli et 
al.,  1988),  All other antisera were raised in rabbits against synthetic pep- 
tides derived from SRP54. Numbers in brackets indicate the position of the 
peptide  antigen  used  within  the  amino  acid  sequence of SRP54:901 
(88-100), 730 (103-117),  832 (131-149), 903 (149-161), 765 (180-196),  906 
(197-208),  981  (267-280), 982 (321-334),  831  (496-504). 
1,'8 Protease Digestion and Immunoblotting 
SRP was purified from dog pancreas as described (Scoulica et al.,  1987), 
but the sucrose gradient centrifugation was omitted. 100 ~tl of 125 nM SRP 
in 50 mM TEA-HCI pH 7.5, 325 mM potassium acetate, 5 mM magnesium 
acetate, 1 mM DTT was incubated with varying concentrations of V8 pro- 
tease (endoproteinase Glu-C, Boehringer, Mannheim, FRG) as indicated in 
the figure legends for 1 h at 25°C. Protein was either TCA precipitated or 
V8 protease activity was inhibited by addition of PMSF to a final concentra- 
tion of 20 #g/mi and the proteolytic fragments tested for DEAE binding as 
described for a binding assay.  DEAE-unbound and eluted material were 
TCA precipitated. After PAGE on 10-15%  Laemmli-type gels, protein was 
blotted onto nitrocellulose filters (Schleicher & Schiill, Dassel, FRG). Rab- 
bit antisera were used at a dilution of 1:200 and blots were developed with 
alkaline phosphatase-coupled goat anti-rabbit antibodies (Dianova). 
Results 
Deletion Mapping of the SRP7S RNA Binding Site 
of SRel9 
To map regions of SRP19 that are important for its binding 
to SRP7S RNA we generated various truncated derivatives 
of SRP19 (Fig.  1). Full-length SRP19 consists of 144 amino 
acids.  COOH-terminally  shortened  derivatives were  ob- 
tained by translating SRP19 mRNA, which was truncated by 
RNase H at sites specified by complementary oligonucleo- 
tides.  The resulting polypeptides  made up the NH2-termi- 
nal 123, 104, and 84 amino acids respectively. Linearization 
of pSRP19 within the coding region by Xba I results in ex- 
pression of the N-terminal 68 amino acids. The Xba I/Hind 
III fragment of pSRP19 subcloned into the bacterial expres- 
sion vector pDS12/RBSII codes for the COOH-terminal 75 
amino acids. SRP19 and the truncated polypeptides derived 
from it were transcribed in vitro and translated in a wheat 
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pSRP19 is outlined on top of the figure (Lingelbach et al.,  1988). 
The coding region is indicated as an open bar. Full-length SRP19 
and truncated proteins are shown underneath. They were generated 
by oligonucleotide truncation  (SRP19/3, SRP19/8, SRP19/7), cut- 
ting within the coding region of pSRP19 (SRP19/Xba) or subclon- 
ing (SRP19X/H as described in Materials and Methods. For COOH- 
terminal  truncations  the  last  amino  acid  is  indicated,  for  the 
SRP19X/H the starting amino acid is numbered. The capability of 
the polypeptides to form a ribonucleoprotein  particle  (RNP) with 
7S RNA is indicated. 
germ cell-free system. 10 #1 of translation reaction were in- 
cubated with 1 #g SRP7S RNA or 1 #g tRNA as a negative 
control.  20%  of the incubation mixture was TCA precipi- 
tated (T) to monitor for protein synthesis. Protein associated 
with  RNA  was  recovered by batch adsorption  to  DEAE- 
Sepharose. The unbound supernatant fraction (U) was TCA 
precipitated and protein which had bound to the DEAE (B) 
via the RNA was eluted and TCA precipitated. All samples 
were subsequently analyzed by SDS-PAGE and fluorogra- 
phy. The resulting fluorographs were scanned to quantitate 
bound and unbound fractions (B+U=100%).  The fact that 
the sum of bound plus unbound fractions is on average only 
2.5 times rather than four times T reflects loss of protein dur- 
ing the washing steps. As was shown previously by Lingel- 
bach et al. (1988) SRP19 binds specifically to SRP7S RNA 
(86% B, 14% U) and not to tRNA (100% U) (Fig. 2 A, com- 
pare 19/7S RNA and 19/tRNA).  Deletion of the 21  COOH- 
terminal amino acids by truncating the SRP19 mRNA with 
oligonucleotide 19/3 has no influence on the binding of the 
polypeptide to  SRP7S  RNA  (90%  B,  10%  U)  (Fig.  2  A, 
19/3/7S RNA and 19/3/tRNA).  It remains unclear why this 
truncation  gives rise to two polypeptide chains  of slightly 
different  molecular  weight,  but  both  can  still  bind  spec- 
ifically to SRP7S  RNA. 
Further deletions from the COOH terminus, i.e., trunca- 
tion with oligonucleotides  19/8 and 19/7 or linearization of 
the plasmid within the coding region with Xba I, completely 
abolished binding to SRP7S RNA. As an example the effect 
of the truncation with oligonucleotide 19/7 is shown in Fig. 
2  A  (compare 19/7/7S RNA  and  19/7/tRNA).  The COOH- 
terminal  75  amino  acids  when  expressed  from  the  Xba 
I/Hind III fragment subcloned in pDS12/RBSII were also in- 
capable of binding to SRP7S  RNA on their own as shown 
in Fig.  2 B  (compare 19X/H/tRNA  and 19X/H/7S RNA). 
Our  results  suggest that at least the  COOH-terminal 21 
amino acid residues of SRP19 are dispensable for binding to 
SRP7S  RNA in vitro. 
Figure 2. In vitro binding of trun- 
cated  SRPI9  to  SRP7S RNA. 
After in  vitro transcription  and 
translation COOH-terminally de- 
leted versions of SRP19 (A) and 
one  NH2-terminal truncation  of 
SRP19 (B) were bound to SRP7S 
RNA in vitro and the assembled 
SRP subparticle  recovered  by bind- 
ing to  DEAE-Sepharose.  tRNA 
was used instead of SRP7S RNA 
as negative control.  20%  of the 
total incubation mixture (T), ma- 
terial which bound to DEAE (B) 
and material not bound to DEAE 
(U) were analyzed by SDS-PAGE 
and  fluorography.  SRP19/3 and 
SRP19/7 are translation products 
of mRNAs truncated by the pres- 
ence  of  the  respective  oligo- 
nucleotides  during  translation. 
SRP19X/H is the translation prod- 
uct of  the Xba I/Hind III  fragment 
of pSRPI9 subcloned into pDS12/ 
RBSII. 
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SRP54 and a COOH-terminally  mmcated SRPI9 
protein.  Full-length  SRP54 and  either  full- 
length  SRPI9  or  SRP19/3, which  lacks the 
COOH-terminal  21  amino  acids  were  in- 
cubated with SRP7S RNA or tRNA and total 
(T), DEAE-bound (B), and unbound (U) ma- 
terial were analyzed as described in Fig. 2. 
Effect of  SRP19 Truncations on Binding of  SRP54 to 
the SRP Subparticle In Vitro 
As  SRP19  binds to 7S RNA and  mediates the binding of 
SRP54 to the ribonucleoprotein particle, we wanted to know 
whether two distinct regions of SRP19 are responsible for 
SRP54 binding to the SRP19/7S RNA subparticle and SRP19 
binding to SRP7S RNA. Since only the COOH-terminal 21 
amino acids of SRP19 are dispensable for 7S RNA binding, 
we tested whether this part of SRP19 is necessary for SRP54 
binding to the subparticle in vitro. The binding assay was 
performed as described above but this time in vitro synthe- 
sized SRP54 in addition to SRP19 or SRP19/3 was incubated 
with SRP7S RNA or tRNA. As shown in Fig. 3, truncation 
of the COOH-termina121 amino acids of SRP19 does not im- 
pair binding of SRP54 to the particle (compare lanes B in 
the presence of 7S RNA).  As expected the SRP19 mutants 
which were unable to bind to SRP7S RNA on their own as 
described above did not promote SRP54 binding to the parti- 
cle (data not shown). 
While  80%  of SRP19  and 93%  of SRP19/3  bind to 7S 
RNA only 43 and 36% of SRP54 are in the bound fraction. 
This considerable difference in binding efficiency between 
SRP19 and SRP54 is consistent in all our experiments. One 
possible explanation for this observation is that SRP19 forms 
a  binary  complex with  SRP7S  RNA  and  the  amount  of 
SRP7S RNA in the binding assay is not limiting, thus the 
chance for SRP19 to bind to SRP7S RNA is high compared 
with that of SRP54 to bind to the small fraction of SRP7S 
RNA that is complexed with SRP19. 
Deletion Mapping of the SRP Binding Region 
of  SRP54 
Our initial approach to identify the region of SRP54 respon- 
sible for its binding to the SRP was similar to our experi- 
ments  with  SRP19:  as  shown in  Fig.  4,  a  set of COOH- 
terminal truncations of SRP54 were generated by linearizing 
the pSRP54-1 plasmid with restriction enzymes cutting with- 
in the coding region. In the SRP54B* truncation the COOH- 
terminal  38  amino  acids  of SRP54  were replaced by six 
histidine residues. In addition, a NHE-terminally truncated 
SRP54 eDNA was used which codes for the COOH-terminal 
35-kD segment of SRP54 (SRP54Ex). 
All SRP54 deletions were tested for binding to the SRP7S 
RNA in the presence and also in the absence of SRP19.  As 
shown previously (R6misch et al.,  1989; Siegel and Walter, 
1988b) both SRP54 and SRP19 bind specifically to SRP7S 
RNA (36 and 62% B, respectively) and not to tRNA (0% B 
for  both)  (Fig.  5  A).  The  translation  product  from  the 
SRP54B* truncation was still capable of binding to the SRP 
subparticle (Fig. 5 A) with an efficiency similar to SRP54: 
in this experiment 86% of SRP19 was bound to 7S RNA and 
49 % of SRP54B* could bind to the subparticle.  SRP54B* 
could not bind to 7S RNA in the absence of SRP19 (Fig. 5 
A). Deletion of a  14kD fragment from the COOH terminus 
by cutting pSRP54-1 with BgllI prior to in vitro transcription 
and translation completely impaired binding of the truncated 
polypeptide to the SRPI9/7S RNA complex (lanes B for 54Bgl 
in Fig. 5 B). Further truncations from the COOH-terminus 
also led to polypeptides incapable of binding to the subparti- 
The Journal  of Cell Biology,  Volume 111, 1990  1796 Figure 4. Schematic outline of SRP54 and derivatives. Fig. 4 shows 
an outline of pSRP54-1 (RSmisch et al., 1989). The coding region 
is represented by an open bar and the following restriction sites are 
indicated: S, Sph I; H, Hind III; E, Eco RI; Ba, Bam HI; Bg, Bgl 
II. Full-length SRP54 is shown underneath. N, G, and M designate 
the proposed domain structure of the protein based on the presence 
of a GTP-binding consensus motif  (G) and accumulation of  methio- 
nine residues (M) (R6misch et al., 1989). Coding regions and size 
of truncated  derivatives of SRP54 are outlined underneath.  The 
names of the resulting polypeptides are given on the lefthand side. 
H6 indicates the addition of six histidine residues to the COOH ter- 
minus of the SRP54B* coding region.  Size in number of amino 
acids  and  capability  of the  polypeptides  to  form  a  RNP  with 
SRP19/7S RNA are indicated on the right hand side. 
cle (data  not shown).  SRP54Ex lacking the NH2-terminal 
19  kD  of  the  full-length  protein  also  did  not  bind  to 
SRP19/7S RNA (Fig.  5  C). 
Identification of the SRP54M Domain as the Region 
Binding to SRP19/7S RNA In Vitro 
The finding that all our random large truncations of SRP54 
rendered it incapable of binding to SRP19/7S RNA led us to 
believe that they might cause a severe perturbance of the ter- 
tiary  structure of the  protein.  Therefore they  might  give 
negative results in the binding assay even though the primary 
sequence responsible  for binding  is  still  contained in  the 
polypeptide.  We  therefore tried  to  maintain  the  tertiary 
structure by generating a  mutant  protein that ends at  the 
predicted domain boundary between the G  and the M  do- 
main of SRP54  (SRP54N+G;  Fig.  4  and RSmisch et al., 
1989). We also created a mutant which expresses only the 
COOH-terminal M-domain of SRP54 (SRP54M; Fig. 4 and 
RSmisch et al.,  1989). 
Binding experiments to SRP7S RNA were performed as 
described above in presence or absence of SRP19.  As shown 
in  Fig.  6  A  the  SRP54N+G  domain  does  not  bind  to 
SRP19/7S RNA (lanes B). However the SRP54M domain on 
its own is capable of specifically binding to the subparticle 
(37%B) but not to SRP7S RNA alone (Fig. 6 B). We there- 
fore conclude that the SRP54M domain is the part of the pro- 
tein that is necessary and sufficient for binding of SRP54 to 
the SRP. 
SRP54 Binds to SRP via its M Domain In Vivo 
We wanted to test whether binding of SRP54 via its M do- 
main to SRP19/7S RNA in vitro reflects the situation in vivo. 
Therefore we looked for a protease that would cleave SRP54 
into large fragments that could easily be identified. It has 
been shown that elastase cleaves a 35-kD fragment off SRP54 
and that this fragment does not bind to SRP anymore (Scoul- 
ica et al., 1987). The 35-kD fragment is comparatively pro- 
tease resistant but the rest of SRP54 is completely digested 
by elastase into small peptides (data not shown). We used 
V8 protease (endoproteinase-GluC) in increasing concentra- 
tions to digest SRP purified from dog pancreas. The digested 
SRP was TCA precipitated, proteolytic fragments separated 
on 10-15 % polyacrylamide gels and blotted onto nitrocellu- 
lose. Blots were probed with an antiserum raised against a 
protein fragment corresponding to amino acids  167-466 of 
SRP54  (907),  an antiserum against  amino acids  1-166  of 
SRP54 (908) and an antiserum against the COOH-terminal 
9  amino acids of SRP54  (831).  At  10/zg/ml V8  protease 
cleaves SRP54 into two fragments (Fig. 7 A, 907): immuno- 
blotting  revealed  that  the  35-kD  fragment  contains  the 
NH2-terminal part of the protein  (Fig.  7 A,  908) and the 
24-kD  fragment contains the COOH terminus (Fig.  7  A, 
831). One or both fragments migrate slightly aberrantly in 
the polyacrylamide gel and therefore add up to >54 kD. In- 
creasing  concentrations of V8  protease lead  to  a  further 
digestion of the NH2-terminal 35-kD fragment to a 32- and 
finally an 18-kD fragment, which are still recognized by an- 
tiserum 908 (Fig. 7 A, open arrowheads). The COOH-ter- 
minal 24-kD fragment is processed to a 21-kD polypeptide 
(Fig. 7 A, black arrowheads).  Undigested SRP54 is shown 
as a control. 
To test which of the proteolytic SRP54 fragments are still 
associated with SRP we digested SRP with 10/zg/ml V8 and 
incubated the fragments with DEAE-Sepharose as described 
above for the binding experiments. DEAE-bound (B) and un- 
bound fractions (U) were analyzed by SDS-PAGE and immu- 
noblotting. Undigested SRP was used as a positive control 
for DEAE-binding. The 35-kD NH2-terminal fragment does 
not bind to SRP as it is recovered in the DEAE-unbound 
fraction (Fig. 7 B). The 24-kD COOH-terminal fragment is 
found in the DEAE-bound fraction and therefore still as- 
sociated with the particle (Fig. 7 B). At the V8 protease con- 
centration used the SRP19 in the particle is completely pro- 
tease resistant (data not shown). 
We characterized the proteolytic fragments from the V8 
digestion more precisely by immunoblotting with a number 
of antisera raised against SRP54-derived peptides. In Fig. 7 
D the position of the peptides used as antigens for the respec- 
tive sera is indicated on a schematic outline of SRP54. Sera 
reacting with the 35-kD fragment are indicated by an open 
arrowhead, sera reacting with the 24-kD fragment by a black 
arrowhead. We conclude that the 35-kD fragment comprises 
most of the SRP54N+G domain and  the 24-kD fragment 
most of the SRP54M domain. 
We used SDS-PAGE and autoradiography in combination 
with immunoblotting to compare the relative molecular sizes 
of the in vitro expressed SRP54N+G and M domains to the 
SRP54 derived V8  fragments. In vitro expressed [asS]me- 
thionine-labeled SRP54,  SRP54N+G  and  SRP54M  were 
separated on a  10-15% polyacrylamide gel. Dog pancreas 
SRP undigested or digested with 10/zg/ml V8 protease was 
applied to the same gel. Protein was blotted onto nitrocellu- 
lose and visualized by autoradiography and immunoblotting. 
ROmisch et al. SRP54 Binds to RATA via its M  Domain  1797 Figure 5. In vitro binding of SRP54 deletion 
mutants to the SRPI9/7S RNA subparticle. 
A shows a binding experiment performed 
with the SRP54B* truncation.  Binding of 
SRP54 was done as a positive control, incu- 
bation with tRNA as negative control. Total 
(T), unbound (U), and bound (B) fractions 
were analyzed as described  in Fig. 2.  B 
shows binding experiments using a SRP54 
COOH-terminal deletion created by cutting 
within  the  coding  region  with  Bgl  II 
(SRP54Bgl). C shows the same type of ex- 
periment  done  with  the  NH2-terminal 
SRP54 deletion mutant SRP54Ex. 
The first three lanes of Fig. 7 C show the in vitro translation 
products, lanes 4 and 5 show the immunoblot with antiserum 
907 on the undigested and digested SRP,  respectively. The 
in vitro synthesizeJt and dog pancreas SRP54 comigrate. As 
judged from the migration in the SDS-gel, the in vitro syn- 
thesized SRP54N+G is ~1 kD smaller than the 35-kD V8 
fragment and the SRP54M is ~1 kD larger than the 24-kD 
V8  fragment.  We therefore conclude that the V8  cleavage 
site in SRP54 is located 8-10 amino acids COOH-terminal 
to our assigned G-M domain boundary at amino acid 297 
(Fig. 7 D). 
The SRP54M Domain Binds to E. coil 4.5S RNA 
E. coli 4.5S RNA is homologous to stem-loop 2 of SRP 7S 
RNA  (Poritz et al.,  1988).  As  we could show previously 
that SRP54 can bind to E. coli 4.5S RNA in the absence of 
SRP19 (Ribes et al.,  1990 and Fig.  8), we wanted to test 
whether the SRP54M domain is also responsible for this in- 
teraction. Binding to 4.5S RNA was performed as described 
above for SRP7S RNA.  Fig.  8 shows that the SRP54N+G 
domain does not bind to 4.5S RNA (compare 54N+G/4.5S 
and 54N+ G/tRNA, lanes B). However, the SRP54M domain 
specifically binds  to E.  coli  4.5S  RNA  (Fig.  8,  compare 
54M/4.5S and 54M/tRNA). In this experiment 57% of the 
SRP54M domain are in the bound fraction that is compara- 
ble to 45 % B for full-length SRP54. These bound ratios are 
higher than those found for SRP54M and SRP54 binding to 
SRP19/7S RNA (37% B and on average 38% B, respective- 
ly). The bound fractions are consistently larger in repeated 
experiments (data not shown) if  binding of SRP54 and deriv- 
atives to 4.5S RNA rather than to the SRP19/7S RNA com- 
plex is tested. This might reflect that the chance for SRP54 
to form a binary complex with nonlimiting amounts of 4.5S 
RNA is higher than to interact with the small fraction of 
SRP7S RNA that has complexed SRP19. 
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RNA subparticle in vitro. (A) SRP54N+G was synthesized in vitro 
by translating SRP54 mRNA in the presence of an oligonucleotide 
complementary to the nucleotides coding for the end of the G do- 
main. Assembly with SRP7S RNA in the presence or absence of 
SRP19 was assayed as described above and total (T), unbound (U), 
and bound (B) fractions were analyzed. (B) The SRP54M domain 
was expressed in vitro from pSRP54M and binding to SRP7S RNA 
was tested in the presence or absence of SRP19 as described above. 
Discussion 
Using a deletion-mapping and limited proteolysis approach 
we  have  studied  the  interactions  between  SRPTS  RNA, 
SRP19, and SRP54. Our deletion experiments with SRP19 
revealed that the integrity of a major part of the protein is 
essential for binding to SRP7S RNA. We could only delete 
the COOH-terminal 21 amino acids without interfering with 
binding and thereby rule out the possibility that the seven ly- 
sine residues clustered in this region are responsible for an 
electrostatic interaction with the negatively charged RNA. 
Truncation of 400 amino acids from the COOH terminus led 
to a complete abolishment of binding. Deletion of the NH2- 
terminal 68 amino acid residues also resulted in a loss of the 
SRP7S RNA  binding function. This may indicate that the 
binding of SRP19 to 7S  RNA is not mediated by a  single 
small stretch of amino acids but rather by multiple contacts 
between protein and RNA which require an intact tertiary 
structure of  the protein. This interpretation is also supported 
by footprinting data from Siegel and Walter (1988a),  who 
could show that SRP19  interacts with the two large stem- 
loops  of SRP7S  RNA.  Alternatively,  the  larger deletions 
might create an incomplete domain which could interfere 
with correct folding of the RNA-binding domain and thus 
abolish  binding  to  SRP7S  RNA  even though  the  deleted 
portion of SRP19  is  not  itself physically interacting with 
the RNA. 
The in vitro translation products derived from truncated 
mRNAs we use in our binding assays are released from the 
ribosomes with EDTA. It is therefore conceivable that ini- 
tially they still have tRNA bound to their COOH terminus 
which may interfere with binding to SRP7S RNA. Peptidyl- 
tRNA would be expected to bind to DEAE-Sepharose in the 
absence of SRP7S RNA.  No such background binding was 
observed  (Fig.  2  A,  compare 19/tRNA to  19/3/tRNA  and 
19/7/tRNA) and one of the translation products derived from 
a truncated mRNA (19/3) was still capable of binding to 7S 
RNA (Fig. 2 A). Therefore we assume that the 15-min incu- 
bation time in presence of EDTA at the end of the translation 
is sufficient for removal of the tRNA from the polypeptide 
chains. 
The COOH-terminal 21 amino acids of SRP19 are also not 
essential for the promotion of SRP54 binding to the particle 
in vitro. SRP19 mutants that did not bind to SRP7S RNA also 
did not mediate SRP54 binding to SRP7S RNA, suggesting 
that these two functions are closely related and are not con- 
tained in two different domains of SRP19 as we thought ini- 
tially.  It is not clear whether the COOH terminus of SRP19 
is also dispensable for SRP function in vivo. 
By two different approaches, deletion mapping and limited 
proteolysis, we could show that the methionine-rich COOH- 
terminal M domain of SRP54 (Fig. 4) is responsible for its 
binding to the SRP. The exact binding site within this domain 
has  not  yet  been  determined.  Removal  of  the  COOH- 
terminal 38 amino acids from SRP54 (SRP54B*, Fig. 4) does 
not interfere with binding to SRP19/7S RNA.  Bernstein et 
al. (1989) proposed that the SRP54M domain forms four am- 
phipathic or-helices (1, 2, 3A and 3B). Due to amino acid se- 
quence homology the authors further suggest that helix 3B 
is a repeat of helix 3A.  In SRP54B* helix 3B is truncated 
approximately in the center. Only one of the 3A-, 3B-type 
helices is present in the E. coli 48-kD protein that is homolo- 
gous to SRP54 and can bind to SRP7S RNA in vivo if 7S 
RNA is expressed in E.  coli (Ribes et al., manuscript sub- 
mired for publication). Together, this information suggests 
that  helix  3B  is  dispensable  for  binding  of  SRP54  to 
SRP19/7S RNA. Truncation of SRP54 at the Bgl II site lo- 
cated between helix 1 and 2 shows that the NH2-terminal 50 
amino acids of the M domain are not sufficient for particle 
binding.  The COOH-terminal proteolytic V8  fragment of 
SRP54 has potentially lost some of or-helix  1, which would 
further  reduce  the  minimal  required  unit  for binding  to 
SRP19/7S RNA. We will answer this question by protein se- 
quencing to locate the V8 cleavage site exactly. 
That a truncated SRP54 that contains part of  the G domain 
in addition to the M domain (SRP54Ex, Fig. 4) cannot bind 
to SRP (Fig. 5 C) suggests that correct folding of the G do- 
main is required for particle binding of the M  domain. 
We have recently shown that SRP54 and its 48-kD E. coli 
homologue can  bind to E.  coli 4.5S  RNA  (Ribes  et al., 
manuscript submitted for publication) that is homologous to 
stem-loop 2 of SRP7S RNA (Poritz et al.,  1988). We have 
shown here that it is the SRP54M domain that mediates this 
RNA binding (Fig.  8). We suggest that in SRP the SRP19 
changes the conformation of SRPTS RNA such that the bind- 
ing site for SRP54 becomes accessible. However, footprint- 
ing data from Siegel and Walter speak against this hypothesis 
(1988a).  They showed that the pattern of protected bands 
Rtmisch et al. SRP54 Binds to RNA  via its M  Domain  1799 Figure  7. The SRP54M domain binds to SRP in vivo. (A) Per lane 100 ttl of 125 nM dog pancreas SRP was digested with the indicated 
amounts of V8 protease for 1 h at 25°C, the fragments separated on a 10-15 % polyacrylamide  gel and blotted onto nitrocellulose. SRP54 
fragments were visualized by probing with rabbit antisera 907, 908,  and 831 (raised against the SRP54 derived peptides indicated in D). 
SRP54 fragments containing the NH2-terminal part of the protein are indicated by open arrowheads, fragments containing the COOH- 
terminus are indicated by black arrowheads. (B) Dog pancreas SRP was digested with 10/~g/ml V8 protease as described above and the 
resulting fragments were incubated with DEAE-Sepharose as described for the in vitro binding assays. DEAE-bound (B) and unbound 
(U) fractions were analyzed by SDS-PAGE and the rabbit antisera described above. (G) In vitro synthesized [3~S]met-labeled SRP54, 
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SRP54M to E.  coli 4.5S RNA in vitro. 
SRP54N+G and SRP54M were synthe- 
sized in vitro and association with 4.5S 
RNA was tested as described  in Fig. 2. 
Binding of full-length SRP54 was done 
as positive control, assembly in the pres- 
ence of tRNA as negative control.  Total 
(T), DEAE-bound (B), and unbound (U) 
material  was  analyzed  by  SDS-PAGE 
and fluorography. 
does not change whether SRP19 alone or SRP19 and SRP54 
are bound to SRP7S RNA.  One possible explanation com- 
patible with a SRP54/7S RNA interaction is that stem-loops 
1 and 2 of SRFTS RNA are stacked on top of each other in 
presence  of SRP19  alone  (Zwieb  and  Ullu,  1986).  Both 
loops could thus be protected from RNase digestion. In the 
presence of both SRP19 and SRP54 the 7S RNA may have 
a different conformation in which SRP19 is bound to stem- 
loop 1 and SRP54 to stem-loop 2.  Different conformations 
for SRP7S  RNA have been proposed previously by Zwieb 
and Ullu (1986).  We assume that in the absence of SRP19 
stem-loop 1 interferes with SRP54 binding to stem-loop 2 
of SRP7S  RNA since SRP54 can bind to 4.5S RNA which 
is homologous to stem-loop 2  and SRP19 does not bind to 
4.5S RNA (data not shown). We are currently testing our hy- 
pothesis by using deletion mutants of SRP7S RNA to iden- 
tify the regions which interact xoith SRP19 and potentially 
with SRP54. 
Many proteins that are associated  with RNA-like mam- 
malian A1 hnRNP proteins or yeast poly(A)-binding protein 
contain  a  RNP  consensus  sequence  (Adam  et  al.,  1986; 
Bandziulis et al.,  1989).  This consensus sequence is a con- 
tinuous  stretch of 10-13  amino acids that can be repeated 
several times (Robinow et al.,  1988)  and that is thought to 
be responsible for the interaction with the RNA.  However, 
there are precedents  for RNP proteins,  which  like SRP54 
lack the RNP consensus sequence (Sillekens et al.,  1988). 
We have identified here a novel type of RNA binding domain 
that is very polar and has an overall basic character and an 
unusually  high methionine content  (11%)  (R6misch et al., 
1989; Bernstein et al.,  1989).  The RNA binding of this do- 
main is very specific and clearly not only due to ionic inter- 
actions  between  the  basic  polypeptide and  the  negatively 
charged RNA since SRP54 binds only to the SRP7S RNA- 
related 4.5S RNA and not to tRNA (Fig.  8). 
SRP54  has  two  known  functions:  binding  to  SRP  and 
binding to the signal sequence of nascent secretory proteins 
(Krieg et al.,  1986; Wiedmann et al.,  1987).  Here we were 
able to show that SRP binding of SRP54 is mediated by its 
M domain. Bernstein et al. (1989) discussed a possible signal 
sequence binding function for the SRP54M domain because 
the hydrophobic face of the four predicted amphipathic a-he- 
lices could interact with the hydrophobic part of the signal 
sequence. Our results do not rule out this possibility, but we 
think  it  is  more likely that  the  signal binding  function  of 
SRP54 is not contained in the same region as SRP binding. 
As discussed previously (R6misch et al.,  1989), we favor the 
hypothesis that the signal sequence interacts with a region in 
the G domain, possibly between the first and the second GTP 
binding  consensus  motif.  The  homologous region  in  Ras 
proteins has been identified as the effector binding site (De- 
ver et al.,  1987)  and  undergoes  a  conformational change 
upon GTP hydrolysis (Pai et al.,  1989). 
In this work, we characterized the SRP54M domain as a 
novel type of RNA binding domain. We are now aiming at 
the  identification  of the  signal  sequence  binding  site  of 
SRP54. 
We would like to thank Peter Walter for communicating unpublished 
results about  V8 protease  digestion  of  SRP, Philippe  Neuner for the synthe- 
sis of the truncating oligonucleotides, Stephen High for help while raising 
the peptide antibodies, Dietrich Stiiber for the pDS plasmids, Maurille 
SRP54N+G, and SRP54M and dog pancreas  SRP digested with  10 #g/ml V8 protease were separated on a 10-15 % polyacrylamide gel 
and blotted onto nitrocellulose.  Lanes 1-3 show an autoradiography  of the [35S]met-labeled  proteins,  lanes 4 and 5 show an immunoblot 
with antiserum 907 on undigested and digested dog pancreas SRP. D shows a schematic outline of SRP54 and the protein segments against 
which antibodies were raised.  Positions of the antigenic peptide for the respective anti-SRP54 rabbit antisera are indicated by arrowheads. 
Open arrowheads  specify antisera  reacting with the 35-kD V8 fragment of SRP54,  black arrowheads specify antisera reacting with the 
24-kD V8 fragment of SRP54. The black bars indicate SRP54 fragments against which antisera were raised (amino acid numbers are given 
in italics).  The approximate position of the V8 cleavage site is indicated by an arrow. 
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